journal cover

Skin lesions and treatment with tumor necrosis factor alpha antagonists

Reumatología clinica

Jul 7, 2012

Maria Victoria HernándezRaimon Sanmartí

Download from

Publisher
PubMed

Abstract

The efficacy shown by biological therapy with tumor necrosis factor (TNF) antagonists has led in the recent years to its increased and extended use in different inflammatory arthopathies. Initially, safety studies of these drugs were mainly focused on the risk of infection and the devel...read more

Mentioned in this Paper

Vasculitis
Monoclonal Antibodies
Psoriasis
Necrosis
Joint Laxity, Familial
Antirheumatic Drugs, Disease-Modifying
Morbilliform Drug Reaction
Herpes NOS
Humira
Nevus
Paper Details
References
  • References72
  • Citations7
12345...
  • References72
  • Citations7
1

Feeds With Similar Papers

Systemic Lupus Erythematosus

Systemic lupus erythematosus is an autoimmune disorder which can affect and damage any organ system in the body. It has a diverse range of immunological manifestations and is more prominent in young women, with the exact etiology still unknown. Here is the latest research on systemic lupus erythematosus.

Urticaria

Urticaria, also known as hive, is a vascular reaction of the skin characterized by erythema and wheal formation due to localized increase of vascular permeability. Discover the latest research on urticaria here.

Lupus Vasculitis

Lupus vasculitis is a complication of systemic lupus erythematosus in which the autoimmune response causes the deposition of immune complexes within the blood vessels. Discover the latest research on lupus vasculitis here.

Interferon Signalling

Via interaction with their specific receptors, interferons (IFNs) activate signal transducer and activator of transcription (STAT) complexes. STAT activation initiates the classical Janus kinase-STAT (JAK-STAT) signaling pathway. In this pathway, JAKs associate with IFN receptors and, following receptor engagement with IFN, phosphorylate both STAT1 and STAT2. As a result, an IFN-stimulated gene factor 3 (ISGF3) complex forms—this contains STAT1, STAT2 and a third transcription factor called IRF9—and moves into the cell nucleus. Inside the nucleus, the ISGF3 complex binds to specific nucleotide sequences called IFN-stimulated response elements (ISREs) in the promoters of certain genes, known as IFN stimulated genes. Discover the latest research on interferon signalling here.

Chemokines & Chemokine Receptors

Chemokines are a subset of cytokines which induce chemotaxis in cells expressing chemokine receptors. Chemokines can be broadly categorized into two functional subgroups, homeostatic (basal expression in lymphoid tissues for surveillance purposes) or inflammatory (released during injury to recruit immune effector cells). Chemokine receptors are G-protein coupled receptors which, upon chemokine binding, induce calcium influx into the cell. Find the latest research on chemokines and chemokine receptors here.

Gerstmann-Straussler-Scheinker Disease

Gerstmann-Straussler-Scheinker disease is a rare neurodegenerative disorder caused by prions and characterized by symptoms associated with prion-associated diseases. Here is the latest research.

Muscular Dystrophy

Muscular dystrophy refers to a range of muscle diseases caused by defects in muscle proteins, leading to death of the muscle cells, with loss of muscle tissue, and weakness. Here are the latest discoveries pertaining to this disease.

Chickenpox

Chickenpox is caused by the varicella-zoster virus and leads to skin rashes and blisters. This highly contagious disease can be prevented with vaccines and treated with antivirals. Discover the latest research on Chickenpox here.

Skin Cutaneous Melanoma

Cutaneous melanoma is a cancer of the pigment-producing cells known as melanocytes. While it has a 98 percent five-year survival rate when caught early, thousands of deaths are attributed to this cancer each year. Here is the latest research.

Chickenpox (ASM)

Chickenpox is caused by the varicella-zoster virus and leads to skin rashes and blisters. This highly contagious disease can be prevented with vaccines and treated with antivirals. Discover the latest research on Chickenpox here.

© 2020 Meta ULC. All rights reserved

Skin lesions and treatment with tumor necrosis factor alpha antagonists

Reumatología clinica

Jul 7, 2012

Maria Victoria HernándezRaimon Sanmartí

PMID: 22766431

DOI: 10.1016/j.reuma.2012.04.007

Abstract

The efficacy shown by biological therapy with tumor necrosis factor (TNF) antagonists has led in the recent years to its increased and extended use in different inflammatory arthopathies. Initially, safety studies of these drugs were mainly focused on the risk of infection and the devel...read more

Mentioned in this Paper

Vasculitis
Monoclonal Antibodies
Psoriasis
Necrosis
Joint Laxity, Familial
Antirheumatic Drugs, Disease-Modifying
Morbilliform Drug Reaction
Herpes NOS
Humira
Nevus

Feeds With Similar Papers

Systemic Lupus Erythematosus

Systemic lupus erythematosus is an autoimmune disorder which can affect and damage any organ system in the body. It has a diverse range of immunological manifestations and is more prominent in young women, with the exact etiology still unknown. Here is the latest research on systemic lupus erythematosus.

Urticaria

Urticaria, also known as hive, is a vascular reaction of the skin characterized by erythema and wheal formation due to localized increase of vascular permeability. Discover the latest research on urticaria here.

Related Papers

Paper Details
References
  • References72
  • Citations7
12345...
  • References72
  • Citations7
1

Download from

Publisher
PubMed
/papers/skin-lesions-and-treatment-with-tumor-necrosis/22766431